While the observed LOD for CEA and PSA is also within relevant ranges, early cancer diagnosis requires additional biomarkers, specifically circulating tumor DNAs (ctDNAs) by highly sensitive genetic diagnostics such as the PCR method83. The gene discussed is CEACAM3; the disease is neoplasm.